Global Whole Genome Bisulfite Sequencing Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Whole Genome Bisulfite Sequencing market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

Whole genome bisulfite sequencing is a technology to detect methylation of all chromosome DNA in cells or tissues. Based on the fact that bisulfite can deamination cytosine without methylation in DNA and convert it into uracil, while the methylated cytosine remains unchanged, PCR amplification of required fragments will convert all uracil into thymine, and then high-throughput sequencing of PCR products will be carried out. By analyzing the methylation difference between different samples, we can study the regulation of DNA methylation level on gene expression.



报错

笔记

Single nucleotide resolution methylation profiling at CG, CHG, and CHH sites. differentially methylated sites linked to experimental treatments or sample conditions, understanding cell differentiation or tissue development mechanisms using methylation profiles and early disease and cancer detection by detecting DNA hypermethylation or hypomethylation. These all are the applications of whole genome sequencing which boost the growth of the market.

This report is a detailed and comprehensive analysis for global Whole Genome Bisulfite Sequencing market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Whole Genome Bisulfite Sequencing market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Whole Genome Bisulfite Sequencing market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Whole Genome Bisulfite Sequencing market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Whole Genome Bisulfite Sequencing market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Whole Genome Bisulfite Sequencing

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Whole Genome Bisulfite Sequencing market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Inc, Epigentek Group Inc, CD Genomics, Thermo Fisher Scientific, Inc, Novogene Co., Ltd, PerkinElmer, Inc, Promega Corporation, Nebula Genomics, Agilent Technologies, Qiagen, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Whole Genome Bisulfite Sequencing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Human Gene Testing

Animal Gene Testing

Market segment by Application

Disease Surveillance

Forensic Identification

Fetal Detection

Other

Major players covered

Illumina, Inc

Epigentek Group Inc

CD Genomics

Thermo Fisher Scientific, Inc

Novogene Co., Ltd

PerkinElmer, Inc

Promega Corporation

Nebula Genomics

Agilent Technologies

Qiagen

Macrogen Inc

Oxford Nanopore Technologies plc

Veritas

BGI

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Whole Genome Bisulfite Sequencing product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Whole Genome Bisulfite Sequencing, with price, sales quantity, revenue, and global market share of Whole Genome Bisulfite Sequencing from 2020 to 2025.

Chapter 3, the Whole Genome Bisulfite Sequencing competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Whole Genome Bisulfite Sequencing breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Whole Genome Bisulfite Sequencing market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Whole Genome Bisulfite Sequencing.

Chapter 14 and 15, to describe Whole Genome Bisulfite Sequencing sales channel, distributors, customers, research findings and conclusion.